Biocon receives Health Canada approval for Bosaya and Vevzuo biosimilars to Prolia and Xgeva
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
Denosumab biosimilars approved in Canada to expand access for osteoporosis and cancer-related bone conditions
The transition from an outsourced MRI model to an in-house facility marks more than an infrastructure upgrade
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Growth was broad-based across segments
The ETHICON 4000 Stapler and ETHICON 3D Reloads are now approved for use in both open and laparoscopic surgeries across the European Union
C. P. Radhakrishnan urged graduates to uphold ethical standards and maintain a commitment to patient care
Approval for Albuterol Sulfate inhalation aerosol enables Cipla Limited to enter the $1.5 billion U.S. albuterol market
The system is powered by BrainSense technology, which has received approval from USFDA
CLIRNET plans to expand globally and improve how medical knowledge is shared and used in practice
Subscribe To Our Newsletter & Stay Updated